Vilobelimab to improve clinical outcomes in moderate-to-severe hidradenitis suppurativa through an adjunctive effect on draining tunnels: results of the SHINE double-blind placebo-controlled randomized trial. - Giamarellos-Bourboulis EJ; Jemec GBE; Prens EP; Riedemann NC; Otto I; Weisman J; Pulka G; Nowicki RJ; Kantardjiev V; Pinter A; Thomsen SF; Berneman D; et al. (The British journal of dermatology, 2026)